Tilray Brands, Inc.
TLRY- Exchange
- Nasdaq
- Industry
- Medicinal Chemicals & Botanical Products
- SEC CIK
- 0001731348
No open-market purchases or sales by Tilray Brands, Inc. insiders were filed in the last 90 days; 240 institutions reported holding it in 13F filings for Q2 2026, worth $62.7M in total; no superinvestor holds it.
- Currency
- USD
- Source
- SEC XBRL data (10-K, 10-Q, 20-F, 40-F)
- Updated
- Oct 9, 2026, 1:10 AM ET
Revenue flow, FY2026
Where the revenue went in FY2026, from the income statement below. Green is profit; orange is costs, expenses and taxes. Percentages are shares of revenue; hover over a band or a bar for the exact amount.
Net loss for FY2026: $121.4M (13.3% of revenue).
Income statement
Each column is one fiscal year, newest first.
| Line item | FY2026 | FY2025 | FY2024 | FY2023 | FY2022 |
|---|---|---|---|---|---|
| Period end | May 31, 2026 | May 31, 2025 | May 31, 2024 | May 31, 2023 | May 31, 2022 |
| Filing | 10-K | 10-K | 10-K | 10-K | 10-K |
| Reported | Jul 28, 2026 | Jul 28, 2025 | Jul 29, 2024 | Jul 26, 2023 | Jul 28, 2022 |
| Revenue | $915.5M | $821.3M | $788.9M | $627.1M | $628.4M |
| Cost of revenue | $655.0M | $580.7M | $565.6M | $480.2M | $511.6M |
| Gross profit | $260.4M | $240.6M | $223.4M | $147.0M | $116.8M |
| Operating expenses | $323.5M | $2.52B | $398.1M | $1.52B | $727.2M |
| Research and development | $361.0K | $284.0K | $635.0K | $682.0K | $1.52M |
| Selling, general and administrative | $203.6M | $167.3M | $167.4M | $165.2M | $162.8M |
| Operating income | -$63.0M | -$2.28B | -$174.7M | -$1.37B | -$610.4M |
| Interest expense | $29.9M | $41.3M | $49.3M | $46.6M | $39.7M |
| Income tax | $17.1M | -$121.0M | -$26.6M | -$7.18M | -$6.54M |
| Net income | -$121.4M | -$2.19B | -$245.0M | -$1.45B | -$476.8M |
| EPS, basic | $-1.09 | $-2.46 | $-0.33 | $-2.35 | $-0.90 |
| EPS, diluted | $-1.09 | $-2.46 | $-0.33 | $-2.35 | $-0.90 |
| Weighted shares, basic | 111.8M | 890.3M | 742.6M | 618.0M | 481.2M |
| Weighted shares, diluted | 111.8M | 890.3M | 742.6M | 618.0M | 481.2M |
| Margins and growth | |||||
| Gross margin | 28.4% | 29.3% | 28.3% | 23.4% | 18.6% |
| Operating margin | -6.9% | -277.9% | -22.1% | -218.4% | -97.1% |
| Net margin | -13.3% | -266.3% | -31.1% | -231.6% | -75.9% |
| Revenue growth, year over year | +11.5% | +4.1% | +25.8% | −0.2% | +22.5% |
Balance sheet
Each column is one fiscal year, newest first.
| Line item | FY2026 | FY2025 | FY2024 | FY2023 | FY2022 |
|---|---|---|---|---|---|
| Period end | May 31, 2026 | May 31, 2025 | May 31, 2024 | May 31, 2023 | May 31, 2022 |
| Filing | 10-K | 10-K | 10-K | 10-K | 10-K |
| Reported | Jul 28, 2026 | Jul 28, 2025 | Jul 29, 2024 | Jul 26, 2023 | Jul 28, 2022 |
| Cash and equivalents | $226.0M | $221.7M | $228.3M | $206.6M | $415.9M |
| Short-term investments | $5.29M | $34.7M | $32.2M | $241.9M | – |
| Accounts receivable | $189.2M | $121.5M | $101.7M | $86.2M | $95.3M |
| Inventory | $301.2M | $270.9M | $252.1M | $200.6M | $245.5M |
| Total current assets | $792.1M | $688.6M | $677.7M | $773.0M | $803.5M |
| Property, plant and equipment | $680.2M | $568.4M | $558.2M | $429.7M | $587.5M |
| Goodwill | $752.4M | $752.4M | $2.01B | $2.01B | $2.64B |
| Intangible assets | $42.8M | $21.4M | $915.5M | $973.8M | $1.28B |
| Total assets | $2.33B | $2.07B | $4.22B | $4.31B | $5.45B |
| Accounts payable | $114.5M | $107.3M | $105.4M | $70.8M | $68.6M |
| Short-term debt | $8.78M | $7.18M | $18.0M | $23.4M | $18.1M |
| Total current liabilities | $358.4M | $280.3M | $299.2M | $433.0M | $280.3M |
| Long-term debt | – | – | – | – | $117.9M |
| Total liabilities | $733.1M | $584.8M | $778.5M | $977.3M | $1.01B |
| Shareholders' equity | $1.59B | $1.49B | $3.44B | $3.33B | $4.44B |
Cash flow statement
Each column is one fiscal year, newest first. Free cash flow is operating cash flow minus capital expenditures.
| Line item | FY2026 | FY2025 | FY2024 | FY2023 | FY2022 |
|---|---|---|---|---|---|
| Period end | May 31, 2026 | May 31, 2025 | May 31, 2024 | May 31, 2023 | May 31, 2022 |
| Filing | 10-K | 10-K | 10-K | 10-K | 10-K |
| Reported | Jul 28, 2026 | Jul 28, 2025 | Jul 29, 2024 | Jul 26, 2023 | Jul 28, 2022 |
| Operating cash flow | -$69.1M | -$94.6M | -$30.9M | $7.91M | -$177.3M |
| Capital expenditures | – | $32.9M | $29.2M | $20.8M | $34.1M |
| Free cash flow | – | -$127.5M | -$60.2M | -$12.9M | -$211.3M |
| Depreciation and amortization | – | – | – | – | $154.6M |
| Stock-based compensation | $45.9M | $24.3M | $31.8M | $39.6M | $36.0M |
| Investing cash flow | -$55.8M | -$46.7M | $128.3M | -$285.1M | -$21.5M |
| Financing cash flow | $131.0M | $133.5M | -$75.2M | $70.2M | $128.2M |
| Net change in cash | $7.68M | -$6.67M | $21.7M | -$209.3M | -$72.6M |
| Ratio | |||||
| Stock-based compensation, % of revenue | 5.0% | 3.0% | 4.0% | 6.3% | 5.7% |
Shares outstanding
Common shares outstanding as stated on the cover of each 10-K and 10-Q. The date is the cover date, not the period end; a rising count means dilution.
| Cover date | Shares outstanding | Change in a year | Filing |
|---|---|---|---|
| Oct 6, 2026 | 147.8M | −86.8% | SEC |
| Jul 24, 2026 | 136.2M | −87.6% | SEC |
| Mar 30, 2026 | 116.5M | −88.4% | SEC |
| Jan 6, 2026 | 116.5M | −87.6% | SEC |
| Oct 7, 2025 | 1.12B | +24.3% | SEC |
| Jul 24, 2025 | 1.10B | +30.6% | SEC |
| Apr 4, 2025 | 1.01B | +30.0% | SEC |
| Jan 8, 2025 | 937.7M | +26.2% | SEC |
Notes and known gaps
How these numbers are put together, and what they can't tell you.
- Numbers come from the XBRL data in each period's original 10-K, 10-Q, 20-F or 40-F, or its amendment. They are shown as filed: later filings don't restate earlier periods here.
- Reported is the filing date of the first 8-K with Item 2.02 (results of operations) after the period ended, no later than the 10-Q or 10-K and within 120 days. Companies that release results only in the 10-Q, and foreign companies, which use Form 6-K, have none.
Known gaps
- Foreign companies that file Form 20-F or 40-F have annual statements only: their quarterly results are furnished on Form 6-K, which has no XBRL data.
- EPS and share counts are as reported at the time, not adjusted for later stock splits. Stock splits since Mar 31, 2021, from 13F share counts: 1-for-10 in Q4 2025.
- For ADRs, EPS is per ordinary share, not per ADS (one TSMC ADS is five ordinary shares).
- For banks, revenue may be interest income only, depending on how the bank tags its filings; cost of revenue and gross profit are usually blank.
- Companies with several share classes, such as Berkshire Hathaway, may have no EPS and no cover share count.
- Depreciation and amortization is missing for some companies that report it under their own XBRL tags.